Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN503553 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Leukemia Inhibitory Factor (LIF) (N-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- The immunogen for anti-LIF antibody: synthetic peptide directed towards the N terminal of human LIF
- Description
- Affinity Purified
- Reactivity
- Human, Mouse, Rat, Bovine, Canine, Porcine
- Host
- Rabbit
- Antigen sequence
KVLAAGVVPLLLVLHWKHGAGSPLPITPVNATCAI
RHPCH NNLMNQIRSQ- Epitope
- N-Term
- Vial size
- 50 μg
- Concentration
- 1mg/mL
- Storage
- -20°C
- Handling
- Avoid repeated freeze-thaw cycles.
Submitted references Phase 2 study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal carcinoma.
OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative).
Muntz HG, Malpass TW, McGonigle KF, Robertson MD, Weiden PL
Cancer 2008 Aug 1;113(3):490-6
Cancer 2008 Aug 1;113(3):490-6
OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative).
García-Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M
Cancer investigation 2008 Apr-May;26(3):222-9
Cancer investigation 2008 Apr-May;26(3):222-9
No comments: Submit comment
No validations: Submit validation data